You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 00713-0882


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00713-0882

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
EFFIENT 10MG TAB Cosette Pharmaceutical, Inc. 00713-0882-30 30 343.58 11.45267 2022-09-28 - 2025-08-14 FSS
EFFIENT 10MG TAB Cosette Pharmaceutical, Inc. 00713-0882-30 30 336.33 11.21100 2024-01-01 - 2025-08-14 FSS
EFFIENT 10MG TAB Cosette Pharmaceutical, Inc. 00713-0882-30 30 329.73 10.99100 2023-01-01 - 2025-08-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 3 of 3 entries

Market Analysis and Price Projections for the Drug NDC: 00713-0882

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique 10-digit, three-segment number that identifies the labeler, product, and trade package size of a drug product. For the NDC 00713-0882, each segment provides specific information:

  • The first segment (00713) is the labeler code assigned by the FDA.
  • The second segment identifies the specific strength, dosage form, and formulation of the product.
  • The third segment identifies the package size and type[1][5].

Identifying the Drug

To proceed with the analysis, it is essential to identify the drug associated with the NDC 00713-0882. However, without specific details on the drug name, we can infer general trends and factors influencing drug prices and market dynamics.

Market Trends in the Pharmaceutical Industry

Specialty Pharmaceuticals

The pharmaceutical industry is experiencing significant growth driven by specialty pharmaceuticals, which treat complex or chronic conditions such as cancer, infectious diseases, autoimmune diseases, and pulmonary conditions. These drugs are characterized by high costs and complex treatment regimens. For instance, Vizient projects a 3.8% increase in drug prices in 2024, largely driven by specialty pharmaceuticals, including weight loss drugs and gene therapies[2].

Advanced Therapies

The rise of advanced therapies, including immunotherapies and targeted therapies, is a key trend. In the non-small cell lung cancer (NSCLC) market, for example, immunotherapies such as Keytruda, Opdivo, and Tecentriq are projected to dominate the market by 2025, with sales reaching $17.5 billion. Targeted therapies, such as Tagrisso and Avastin, are also expected to contribute significantly to market growth[4].

Price Projections

General Trends

Drug price inflation is expected to continue, with a projected 3.8% increase in 2024. This increase is driven by several factors, including the rising costs of specialty pharmaceuticals and the expansion of gene therapies[2].

Specific to NDC 00713-0882

Without specific details on the drug associated with NDC 00713-0882, it is challenging to provide precise price projections. However, if the drug falls under the category of specialty pharmaceuticals or advanced therapies, it is likely to follow the general trend of increasing prices.

Factors Influencing Drug Prices

Regulatory Environment

The FDA's regulatory environment plays a crucial role in drug pricing. The approval process, including New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs), affects the market availability and pricing of drugs. For instance, the FDA's review of safety, effectiveness, and manufacturing processes can impact the cost and pricing strategy of a drug[1].

Market Competition

The level of competition in the market also influences drug prices. For example, in the NSCLC market, the launch of new immunotherapies and targeted therapies can lead to competitive pricing strategies among manufacturers. However, the high cost of these therapies, such as the combination of durvalumab and tremelimumab, can limit their uptake due to cost considerations[4].

Patent Expirations

Patent expirations can significantly impact drug prices. As patents expire, generic versions of the drugs can enter the market, leading to a decrease in prices. For instance, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[4].

Impact of Technological Advancements

Digital Manufacturing and Big Data

The pharmaceutical industry is embracing advanced technologies, including digital manufacturing systems and big data analytics. These advancements can improve operational efficiency and reduce costs, potentially influencing drug pricing. However, the initial investment in these technologies can also drive up costs in the short term[3].

Security and Data Protection

As the pharmaceutical industry becomes more reliant on digital systems and big data, the need for robust security measures to protect data sets increases. This can add to the operational costs and potentially affect drug pricing[3].

Physician and Patient Perspectives

Physician preferences and patient needs also play a crucial role in drug market dynamics. For instance, in the NSCLC market, physicians are increasingly adopting immunotherapies and targeted therapies due to their efficacy. However, the high cost of these treatments can be a barrier to access, influencing market uptake and pricing strategies[4].

Key Takeaways

  • Specialty Pharmaceuticals: Drugs treating complex conditions are driving market growth and price increases.
  • Advanced Therapies: Immunotherapies and targeted therapies are becoming dominant in markets like NSCLC.
  • Regulatory Environment: FDA approvals and regulatory compliance impact drug pricing.
  • Market Competition: Competitive pricing strategies among manufacturers influence market dynamics.
  • Technological Advancements: Digital manufacturing and big data can improve efficiency but may initially increase costs.
  • Security and Data Protection: Robust security measures are necessary but add to operational costs.

FAQs

1. What is the National Drug Code (NDC) and how is it used? The NDC is a unique 10-digit number that identifies the labeler, product, and trade package size of a drug product. It is used to track and report drug products to the FDA.

2. Why are specialty pharmaceuticals driving drug price increases? Specialty pharmaceuticals treat complex or chronic conditions and are often priced higher due to their complexity, efficacy, and the cost of development.

3. How do patent expirations affect drug prices? Patent expirations allow generic versions of drugs to enter the market, leading to a decrease in prices as competition increases.

4. What role do technological advancements play in drug pricing? Technological advancements like digital manufacturing and big data analytics can improve operational efficiency and reduce costs in the long term but may initially increase costs due to investment requirements.

5. How do regulatory approvals impact drug pricing? Regulatory approvals by the FDA influence the market availability and pricing of drugs by ensuring safety, effectiveness, and compliance with manufacturing standards, which can affect the cost and pricing strategy of a drug.

Sources

  1. FDA: National Drug Code Database Background Information.
  2. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  3. Apprentice.io: Top 10 Pharma Trends for 2024.
  4. GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. Wikipedia: National drug code.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.